Women's Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Kurume University School of Medicine, Fukuoka
Reports add new data to cervical cancer research
February 5th, 2006
Data on cervical cancer are outlined in reports from Japan, the Czech Republic and Wales. Study 1: Human papillomavirus 16-E6 protein-derived peptides generate cytotoxic T lymphocytes toward HLA-A241 cervical cancer. "Human papillomavirus 16 (HPV16)-E6 and -E7 proteins are considered to be appropriate targets in specific immunotherapy for cervical cancer. In this study, we attempted to identify epitope peptides from the HPV16-E6 protein that have the potential to generate cytotoxic T-lymphocytes (CTLs) toward human leukocyte antigen (HLA)-A24+ cervical cancer," investigators in Japan report. "Two HPV16-E6 peptides at positions...
Source: Women's Health Law Weekly (2006-02-05)
|
